Home > News & Events
Compass Bioinformatics, a subsidiary of BRIM Biotech Inc., proudly announced that its AI-driven rare disease genetic diagnostic platform, InheriNext, was featured at the 70th Annual...
Mastermind® FLEX Data powers Compass Bioinformatics’s InheriNext® platform, bringing unparalleled genomic evidence to leading institutes across US, Japan, and beyond while advancing precision medicine globally....
This week, Compass Bioinformatics announced that BRIM Biotechnology (TWSE:6885) will acquire a 42% stake in the company through a strategic investment of up to NT$150...
A partnership that goes beyond innovation: It’s a promise to patients, families, and healthcare providers that the future of rare disease management will be precise,...
